Professional Research Network
Goose Creek, South Carolina, 29445, United States
NCT Number: NCT02599688
This is an open-label, observational extension of patients who received POLAT-001 in LipoLat-CS202.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Goose Creek, South Carolina, 29445, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Excluded from the study will be individuals with the following characteristics:
No intervention in this study.
Time frame: 3 months
Mean change from baseline (Visit 1 in Study LipoLat-CS202, NCT02466399) IOP at Month 3 (6 months after treatment in LipoLat-CS202).
Peregrine Ophthalmic
Industry
An Open-label Extension Study of the Safety and Efficacy of Subconjunctival Liposomal Latanoprost (POLAT-001) in Patients With Ocular Hypertension and Primary Open Angle Glaucoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960629
Corneal Diseases, Corneal Edema
Zagreb, Croatia
View Trial DetailsNCT07730424
Eye Diseases, Glaucoma
Fitzroy, Victoria, Australia
View Trial DetailsNCT07168902
Eye Diseases, Glaucoma
Glendale, California, United States
View Trial DetailsNCT04132401
Age-Related Macular Degeneration, Cardiovascular Diseases
Manresa, Barcelona, Spain
View Trial Details